DXN HOLDINGS BHD. — Investor Relations & Filings
DXN HOLDINGS BHD. is a global manufacturer specializing in the cultivation, manufacturing, and marketing of health-oriented and wellness products. Its core offerings include nutraceuticals, health food supplements, and skincare items, often featuring an integrated Ganoderma approach. The company operates worldwide, distributing its diverse product range through a direct sales model to markets across Asia, Latin America, North America, and Africa. DXN maintains a significant global footprint with numerous manufacturing plants and cultivation facilities.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Immediate Announcement on Shares Buy Back | 2026-05-21 | English | |
| Immediate Announcement on Shares Buy Back | 2026-05-19 | English | |
| Immediate Announcement on Shares Buy Back | 2026-05-18 | English | |
| DXN - Notice of Book Closure | 2026-04-29 | English | |
| Quarterly rpt on consolidated results for the financial period ended 28/02/2026 | 2026-04-28 | English | |
| MEMORANDUM OF UNDERSTANDINGDXN HOLDINGS BHD. ("DXNH" OR "COMPANY") UPDATE ON THE STATUS OF MEMORANDUMS OF UNDERSTANDING | 2026-04-28 | English |
Browse filings by year
2 yearsMarket data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
DXN HOLDINGS BHD. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/70510/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=70510 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=70510 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=70510 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 70510}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for DXN HOLDINGS BHD. (id: 70510)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.